Cargando…

Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new

Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or...

Descripción completa

Detalles Bibliográficos
Autores principales: Dixon-Woods, Mary, Amalberti, Rene, Goodman, Steve, Bergman, Bo, Glasziou, Paul
Formato: Texto
Lenguaje:English
Publicado: BMJ Group 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066840/
https://www.ncbi.nlm.nih.gov/pubmed/21450771
http://dx.doi.org/10.1136/bmjqs.2010.046227
_version_ 1782201120815316992
author Dixon-Woods, Mary
Amalberti, Rene
Goodman, Steve
Bergman, Bo
Glasziou, Paul
author_facet Dixon-Woods, Mary
Amalberti, Rene
Goodman, Steve
Bergman, Bo
Glasziou, Paul
author_sort Dixon-Woods, Mary
collection PubMed
description Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or pose risks, while other innovations that could potentially deliver benefits to patients remain slow to achieve uptake. Second, participatory, cooperative approaches may be the best way of achieving sustainable, positive innovation, yet relying solely on such approaches may disrupt positive innovation. Third, improvement clearly depends upon change, but change always generates new challenges. Quality improvement systems may struggle to keep up with the pace of innovation, yet evaluation of innovation is often too narrowly focused for the system-wide effects of new practices or technologies to be understood. A new recognition of the problems of innovation is proposed and it is argued that new approaches to addressing them are needed.
format Text
id pubmed-3066840
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BMJ Group
record_format MEDLINE/PubMed
spelling pubmed-30668402011-04-11 Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new Dixon-Woods, Mary Amalberti, Rene Goodman, Steve Bergman, Bo Glasziou, Paul BMJ Qual Saf The Social Determinants of Action Innovation is often regarded as uniformly positive. This paper shows that the role of innovation in quality improvement is more complicated. The authors identify three known paradoxes of innovation in healthcare. First, some innovations diffuse rapidly, yet are of unproven value or limited value, or pose risks, while other innovations that could potentially deliver benefits to patients remain slow to achieve uptake. Second, participatory, cooperative approaches may be the best way of achieving sustainable, positive innovation, yet relying solely on such approaches may disrupt positive innovation. Third, improvement clearly depends upon change, but change always generates new challenges. Quality improvement systems may struggle to keep up with the pace of innovation, yet evaluation of innovation is often too narrowly focused for the system-wide effects of new practices or technologies to be understood. A new recognition of the problems of innovation is proposed and it is argued that new approaches to addressing them are needed. BMJ Group 2011-04 /pmc/articles/PMC3066840/ /pubmed/21450771 http://dx.doi.org/10.1136/bmjqs.2010.046227 Text en © 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
spellingShingle The Social Determinants of Action
Dixon-Woods, Mary
Amalberti, Rene
Goodman, Steve
Bergman, Bo
Glasziou, Paul
Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title_full Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title_fullStr Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title_full_unstemmed Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title_short Problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
title_sort problems and promises of innovation: why healthcare needs to rethink its love/hate relationship with the new
topic The Social Determinants of Action
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3066840/
https://www.ncbi.nlm.nih.gov/pubmed/21450771
http://dx.doi.org/10.1136/bmjqs.2010.046227
work_keys_str_mv AT dixonwoodsmary problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew
AT amalbertirene problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew
AT goodmansteve problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew
AT bergmanbo problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew
AT glaszioupaul problemsandpromisesofinnovationwhyhealthcareneedstorethinkitslovehaterelationshipwiththenew